Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Comparison effectiveness, side effect and long-term tolerability of amlodipine and cilnidipine

Breadcrumb

  • Home
  • Comparison effectiveness, side effect and long-term tolerability of amlodipine and cilnidipine

Sk Ahammed Hossain 1, Abhijit Sarkar 2, * , Silky Kumari 3,Subhartha Kayal 4 and Animesh Kumar Mishra 5

1 Intern at Department of Clinical Pharmacology and Research, Ruby General Hospital, Kasba, Kolkata-700107,West Bengal, India.

2 Clinical Pharmacologist, Departmemt of Clinical Pharmacology and Research, ILS Hospital, Mall road, Dumdum,Kolkata-700028, India.

3 Clinical Pharmacologist, Departmemt of Clinical Pharmacology and Research, Ruby General Hospital, Kasba, Kolkata-700107,West Bengal, India.

4 Senior Clinical Pharmacist, Departmemt of Clinical Pharmacology and Research, Ruby General Hospital, Kasba, Kolkata-700107,West Bengl,  India.

5 Deputy Medical Superintendent, Ruby General Hospital, Kasba, Kolkata-700107,West Bengal, India.

Review Article

World Journal of Advanced Research and Reviews, 2026, 29(03), 1302-1307

Article DOI: 10.30574/wjarr.2026.29.3.0083

DOI url: https://doi.org/10.30574/wjarr.2026.29.3.0083

Received on 05 December 2025; revised on 14 March 2026; accepted on 17 March 2026

Hypertensive patients usually benefit from selective antihypertensive medications like Calcium Channel Blockers. Amlodipine and Cilnidipine both comes under Calcium Channel Blockers.Both the drugs use widely to control hypertension. Amlodipine is a third generation CCB comes under dihydropyridine and Cilnidipiene is a (long acting dihydropyridine) fourth generation CCB. Both the drugs has an excellent pharmacokinetic and pharmacodynamic profile. Both the drugs has significant percentage of safety and tolerability but Amlodipine has a typical side effect i.e. B/L Pedal edema. Around 5-10% of the patients are suffering from B/L Pedal edema with Amlodipine therapy which can be recovered after switching to Cilnidipine therapy. CCB related edema is caused by preferential arteriolar or precapillary dilation in the venous or postcapillary circulation. Amlodipine works by demonstrate prolonged efficacy by inhibiting voltage dependent L-type calcium channel. Cilnidipine works by blocking L-type & C-type both the calcium channel. Cilnidipine's dual mechanism of action allows for effective blood pressure reduction through vascular smooth muscle relaxation & arterial dilation, while also suppressing catecholamine release from sympathetic nerves. This unique pharmacological profile may explain cilnidipine's lower incidence of adverse effects, including pedal edema.

Amlodipine; Cilnidipine; Pedal edema; N & L type Calcium Channel; CCB

https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2026-0083.pdf

Preview Article PDF

Sk Ahammed Hossain, Abhijit Sarkar, Silky Kumari,Subhartha Kayal and Animesh Kumar Mishra. Comparison effectiveness, side effect and long-term tolerability of amlodipine and cilnidipine. World Journal of Advanced Research and Reviews, 2026, 29(03), 1302-1307. Article DOI: https://doi.org/10.30574/wjarr.2026.29.3.0083.

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution